Logo image of CJMB

CALLAN JMB INC (CJMB) Stock Fundamental Analysis

NASDAQ:CJMB - Nasdaq - US1311001093 - Common Stock - Currency: USD

4.94  -0.04 (-0.8%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CJMB. CJMB was compared to 22 industry peers in the Air Freight & Logistics industry. No worries on liquidiy or solvency for CJMB as it has an excellent financial health rating, but there are worries on the profitability. CJMB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CJMB has reported negative net income.
CJMB Yearly Net Income VS EBIT VS OCF VS FCFCJMB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

CJMB has a worse Return On Assets (-41.80%) than 81.82% of its industry peers.
The Return On Equity of CJMB (-51.92%) is worse than 63.64% of its industry peers.
Industry RankSector Rank
ROA -41.8%
ROE -51.92%
ROIC N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CJMB Yearly ROA, ROE, ROICCJMB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

The Gross Margin of CJMB (39.68%) is better than 81.82% of its industry peers.
CJMB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CJMB Yearly Profit, Operating, Gross MarginsCJMB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40

More info and screens

9

2. Health

2.1 Basic Checks

CJMB does not have a ROIC to compare to the WACC, probably because it is not profitable.
CJMB has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for CJMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CJMB Yearly Shares OutstandingCJMB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CJMB Yearly Total Debt VS Total AssetsCJMB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 7.93 indicates that CJMB is not in any danger for bankruptcy at the moment.
The Altman-Z score of CJMB (7.93) is better than 95.45% of its industry peers.
There is no outstanding debt for CJMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.93
ROIC/WACCN/A
WACC8.86%
CJMB Yearly LT Debt VS Equity VS FCFCJMB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5M 10M

2.3 Liquidity

A Current Ratio of 6.48 indicates that CJMB has no problem at all paying its short term obligations.
CJMB has a better Current ratio (6.48) than 95.45% of its industry peers.
CJMB has a Quick Ratio of 6.28. This indicates that CJMB is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CJMB (6.28) is better than 95.45% of its industry peers.
Industry RankSector Rank
Current Ratio 6.48
Quick Ratio 6.28
CJMB Yearly Current Assets VS Current LiabilitesCJMB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CJMB have decreased strongly by -205.15% in the last year.
CJMB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.29%.
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CJMB Yearly Revenue VS EstimatesCJMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CJMB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJMB Price Earnings VS Forward Price EarningsCJMB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CJMB Per share dataCJMB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CJMB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALLAN JMB INC

NASDAQ:CJMB (8/8/2025, 2:33:51 PM)

4.94

-0.04 (-0.8%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners15.65%
Inst Owner Change0.33%
Ins Owners70.56%
Ins Owner Change0%
Market Cap22.13M
AnalystsN/A
Price TargetN/A
Short Float %0.12%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.76
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.79
BVpS1.52
TBVpS1.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.8%
ROE -51.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.68%
FCFM N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.48
Quick Ratio 6.28
Altman-Z 7.93
F-ScoreN/A
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)375.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-203.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-92.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.28%
OCF growth 3YN/A
OCF growth 5YN/A